Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
US10639351B2 · kind B2 · utility
0Cited by
27References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 22, 2014 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | Nov 6, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4753
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition for preventing or treating amyotrophic lateral sclerosis, the composition containing, as an active ingredient, two or more isoforms of a hepatocyte growth factor (HGF) or a polynucleotide encoding the isoforms. The composition of the present invention is used to effectively prevent or treat amyotrophic lateral sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.